Dose to the dominant intraprostatic lesion using HDR vs. LDR monotherapy: A Phase II randomized trial-Reference-Cited by-同舟云学术

Dose to the dominant intraprostatic lesion using HDR vs. LDR monotherapy: A Phase II randomized trial

Published:2019-05 Issue:3 Volume:18 Page:299-305
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Tissaverasinghe Steven,Crook Juanita,Bachand Francois,Batchelar Deidre,Hilts Michelle,Araujo Cynthia,Anderson Danielle,Bainbridge Terry,Farnquist Brenda

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference41 articles.

1. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008

2. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American college of radiology 95-09;Zietman;J Clin Oncol,2010

3. Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy;Stone;J Urol,2011

4. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer;Al-Mamgani;Int J Radiat Oncol,2008

5. The best method for dose escalation: prostate brachytherapy;Morton;Can Urol Assoc J,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population‐based patient‐reported quality of life outcomes following low‐dose‐rate versus high‐dose‐rate brachytherapy monotherapy for low‐intermediate risk prostate cancer;Journal of Medical Imaging and Radiation Oncology;2023-10

2. Single- and dual-source-strength focal boost planning in low-dose-rate prostate brachytherapy: feasibility study;Journal of Radiotherapy in Practice;2023

3. Brachytherapy focal dose escalation using ultrasound based tissue characterization by patients with non-metastatic prostate cancer: Five-year results from single-center phase 2 trial;Brachytherapy;2022-07

4. Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers;Radiation Oncology;2022-02-22

5. Dose differentiated high-dose-rate prostate brachytherapy: a feasibility assessment of MRI-guided dose escalation to dominant intra-prostatic lesions;Journal of Contemporary Brachytherapy;2022